Legal

Hagens Berman reviews Embecta after class action over insulin pen needle business

Atlas Watchline · August 10, 2026

Key facts

What happened

Hagens Berman is conducting an investigation into Embecta Corp

Key facts

Why it matters

Embecta’s ticker is NASDAQ: EMBC

Key facts

The details

The investigation concerns alleged violations of federal securities laws

Atlas Watchline

Read the full report

Hagens Berman says it is reviewing Embecta Corp. after a New Jersey class action alleged the…

Read on Atlas Watchline

Read on Atlas Watchline